NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 72611-0719-25 — Ketorolac 15 mg/mL injectionAI (213 hospitals, 36,303–37,707 samples)
• NDC 00143-9251-10 — Rocuronium bromide injection, 100 mg per 10 mLAI (197 hospitals, 36,228–37,659 samples)
• NDC 47781-0584-93 — Ketorolac 30 mg/mL injectionAI (121 hospitals, 36,144–37,629 samples)
• NDC 00054-3500-49 — Lidocaine viscous 2% oral solutionAI (638 hospitals, 36,399–37,623 samples)
• NDC 61314-0656-25 — Ciprofloxacin 0.3% eye dropsAI (804 hospitals, 36,197–37,601 samples)
• NDC 70756-0629-25 — Phenylephrine 2.5% eye dropsAI (848 hospitals, 36,350–37,592 samples)
• NDC 00406-9075-76 — FENTANYL 75 MCG/HR TRANSDERMAL PATCHAI (207 hospitals, 36,733–37,579 samples)
• NDC 55150-0188-10 — Tranexamic acid injection, 10 mL vialAI (708 hospitals, 34,671–37,533 samples)
• NDC 00002-8215-01 — Humulin R insulin injection solutionAI (1071 hospitals, 31,056–37,509 samples)
• NDC 00168-0258-15 — Clotrimazole and betamethasone creamAI (736 hospitals, 36,473–37,499 samples)
• NDC 00093-1010-42 — MUPIROCIN 2 % TOPICAL OINTMENTAI (374 hospitals, 36,380–37,487 samples)
• NDC 63323-0161-16 — Ketorolac tromethamine 15 mg/mL injectionAI (234 hospitals, 36,117–37,485 samples)
• NDC 00378-0873-99 — Clonidine 0.3 mg weekly skin patchAI (518 hospitals, 36,060–37,464 samples)
• NDC 47781-0583-68 — Ketorolac 15 mg/mL injectionAI (129 hospitals, 36,325–37,459 samples)
• NDC 61314-0226-05 — Timolol 0.25% eye dropsAI (831 hospitals, 36,364–37,444 samples)
• NDC 65219-0383-50 — Iodixanol 320 contrast injection for intravenous useAI (91 hospitals, 35,924–37,409 samples)
• NDC 00003-0371-13 — Belatacept 250 mg intravenous injectionAI (834 hospitals, 36,547–37,402 samples)
• NDC 50419-0451-04 — Estradiol 0.05 mg weekly patch, 4-pack boxAI (219 hospitals, 36,488–37,397 samples)
• NDC 24208-0635-62 — Neomycin, polymyxin B and hydrocortisone ear dropsAI (1099 hospitals, 36,250–37,375 samples)
• NDC 50419-0452-04 — Estradiol 0.1 mg weekly patch, box of 4AI (226 hospitals, 36,483–37,347 samples)
• NDC 70860-0700-02 — Ketorolac 15 mg/mL injectionAI (224 hospitals, 35,763–37,338 samples)
• NDC 67877-0124-40 — Silver sulfadiazine 1% cream, 400 g jarAI (579 hospitals, 36,328–37,336 samples)
• NDC 00406-9050-76 — Fentanyl 72-hour skin patch, 50 mcg/hrAI (272 hospitals, 36,498–37,308 samples)
• NDC 00338-3508-41 — Cefazolin 2 gram IV piggyback in dextroseAI (334 hospitals, 34,583–37,301 samples)
• NDC 47426-0401-10 — Aprepitant intravenous injection for nauseaAI (111 hospitals, 36,503–37,277 samples)
• NDC 45802-0049-35 — Triamcinolone acetonide 0.5% ointment, 15 g tubeAI (539 hospitals, 36,073–37,171 samples)
• NDC 00009-0047-22 — Methylprednisolone sodium succinate injection 125 mgAI (912 hospitals, 22,489–37,096 samples)
• NDC 45802-0098-46 — Mesalamine 4 g enemaAI (425 hospitals, 36,025–37,051 samples)
• NDC 59584-0138-01 — Candida skin test antigen vialAI (610 hospitals, 35,850–37,029 samples)
• NDC 42023-0104-01 — Aplisol tuberculin skin test solutionAI (702 hospitals, 35,824–37,012 samples)
• NDC 24208-0735-01 — Cyclopentolate eye drops 1%AI (803 hospitals, 35,760–37,011 samples)
• NDC 69315-0905-01 — Lorazepam 1 mg tabletAI (861 hospitals, 35,239–37,003 samples)
• NDC 00409-1560-18 — Bupivacaine (preservative-free) 0.5% numbing injectionAI (208 hospitals, 34,598–37,001 samples)
• NDC 24208-0580-60 — Gentamicin 0.3% eye dropsAI (747 hospitals, 35,839–36,991 samples)
• NDC 69547-0353-02 — Naloxone 4 mg nasal sprayAI (292 hospitals, 36,148–36,985 samples)
• NDC 60505-0823-06 — Calcitonin (salmon) nasal sprayAI (1019 hospitals, 35,822–36,983 samples)
• NDC 71351-0021-25 — Lidocaine 1% injection, 5 mL vialAI (166 hospitals, 34,495–36,979 samples)
• NDC 55150-0252-20 — Lidocaine 1% injection solutionAI (584 hospitals, 23,859–36,972 samples)
• NDC 11980-0180-05 — Prednisolone acetate 1% eye dropsAI (400 hospitals, 35,857–36,937 samples)
• NDC 00245-5319-01 — Potassium chloride extended-release tablets 20 mEqAI (591 hospitals, 35,608–36,931 samples)
• NDC 63323-0506-16 — Dexamethasone sodium phosphate injection, 10 mg/mLAI (341 hospitals, 31,761–36,927 samples)
• NDC 61314-0396-01 — Cyclopentolate 1% eye dropsAI (868 hospitals, 35,537–36,923 samples)
• NDC 67457-0440-00 — Ondansetron 4 mg/2 mL injectionAI (196 hospitals, 35,613–36,918 samples)
• NDC 63323-0540-15 — Heparin sodium injectionAI (626 hospitals, 31,761–36,918 samples)
• NDC 24208-0795-35 — Neomycin, polymyxin B and dexamethasone eye ointmentAI (991 hospitals, 35,611–36,889 samples)
• NDC 24201-0201-01 — Sodium tetradecyl sulfate 3% injectionAI (258 hospitals, 35,986–36,877 samples)
• NDC 00944-2700-07 — Gammagard 30 gram immune globulin infusion solutionAI (654 hospitals, 36,383–36,842 samples)
• NDC 00409-1163-18 — Bupivacaine 0.5% numbing injection solutionAI (265 hospitals, 35,489–36,830 samples)
• NDC 00713-0135-06 — Prochlorperazine 25 mg suppositoryAI (318 hospitals, 35,829–36,828 samples)
• NDC 76204-0200-25 — Albuterol sulfate 2.5 mg nebulizer solutionAI (349 hospitals, 35,300–36,821 samples)